EIR Wyeth BioPharma Division of Wyeth Pharmaceuticals May 2019

Amy Devlin FDA$595.00 - Available Now

FDA investigators audited the Wyeth BioPharma Division of Wyeth Pharmaceuticals - Andover, MA, United States facility and issued inspectional observation (via FDA 483) on 03 May 2019.

Product details

  • Category:
  • Inspection end: 03 May 2019
  • Location: Andover, United States
  • FEI: 1222181
Add To Cart